Target intelligence / Profile preview

Growth arrest and DNA-damage-inducible proteins-interacting protein 1 (GADD45GIP1)

Target
GADD45GIP1
Molecular classification
Ribosomal protein (mitochondrial large ribosomal subunit), Cell cycle regulatory protein, Nuclear protein
01

Overview

Growth arrest and DNA-damage-inducible proteins-interacting protein 1 (GADD45GIP1, also known as CRIF1 and other aliases) is a component of the large mitochondrial ribosomal subunit (mL64/39S ribosomal protein L59, mitochondrial) essential for the translation of oxidative phosphorylation (OXPHOS) proteins in mammalian mitochondria. GADD45GIP1 is a nuclear-localized protein that regulates the cell cycle by inhibiting G1 to S phase progression, acting as a negative regulator of cyclin-dependent kinases and as a repressor for certain transcriptional activities (e.g., NR4A1). It interacts directly with GADD45 family proteins and is inducible by p53, contributing to cell cycle arrest and cellular stress responses. Disruption of GADD45GIP1 function results in defects in mitochondrial protein synthesis, failure of oxidative phosphorylation, and has been observed to cause neurodegeneration in model organisms. GADD45GIP1 has disease relevance in cancer (including ovarian cancer, adrenal adenoma) and may participate in broader networks regulating cell proliferation and survival.

Other names
CRIF1Large ribosomal subunit protein mL64MRPL59PLINP1PRG6MRP-L59CKBBP2CKbetaBP239S ribosomal protein L59, mitochondrialCKII beta-associating proteinCR6-interacting factor 1Papillomavirus L2-interacting nuclear protein 1p53-responsive gene 6 proteinGrowth arrest and DNA damage-inducible proteins-interacting protein 1Plinp1MGC4667MGC4758
02

Mechanism of action

For drugs targeting associated cell cycle or mitochondrial translation pathways (not specific to GADD45GIP1 but mechanistically relevant): - Inhibition of cyclin-dependent kinases (CDKs) - Modulation of mitochondrial translation or oxidative phosphorylation

03

Biological functions

Translation of mitochondrial oxidative phosphorylation (OXPHOS) polypeptidesNegative regulator of G1 to S phase cell cycle progressionRegulation of cyclin-dependent kinases (CDKs)Protein synthesis in mitochondriaRepressor of NR4A1 transcriptional activity
04

Disease associations

Cancer (implicated in cell proliferation and survival signaling in cancer cells; associated with ovarian cancer and adrenal adenoma)Neurodegenerative disease (brain-specific deficiency leads to neurodegeneration via OXPHOS failure in mice)Potential roles in hormone-mediated regulation (NR4A1)
05

Safety considerations

Notable safety or therapeutic challenges are not directly described for this molecule. However, modulation may affect mitochondrial function and cellular metabolism, with theoretical risks of neurodegeneration or impaired cell cycle control.
06

Interacting drugs

No specific drugs targeting GADD45GIP1 are reported; interactions are more commonly described for the protein and its associated pathways rather than for direct pharmacological targeting. Thus, this is currently not a direct drug target based on available literature.
07

Biomarkers

No established clinical biomarkers based on GADD45GIP1 for patient selection or efficacy monitoring. However, its expression or mutation status may be relevant for certain cancer phenotypes.

Beyond the preview

Go deeper on Growth arrest and DNA-damage-inducible proteins-interacting protein 1 (GADD45GIP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growth arrest and DNA-damage-inducible proteins-interacting protein 1 (GADD45GIP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call